Princeton Global Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
MFS
EWM
LHWM
MWA
PI
SWM
MAM
Princeton Global Asset Management's XBI Position: Q2 2026 in Review
Princeton Global Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.92% in Q2 2026, selling an estimated $2.03K and leaving 1,616 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #193.
Princeton Global Asset Management first reported a position in XBI in Q4 2021 and has held it in 14 quarters since. 131 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Princeton Global Asset Management held 1,616 shares of State Street SPDR S&P Biotech ETF worth $256K as of Q2 2026.
- Princeton Global Asset Management sold 15 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.03K.
- State Street SPDR S&P Biotech ETF made up 0.04% of Princeton Global Asset Management's portfolio in Q2 2026, its #193 holding.
- Princeton Global Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 14 quarters since.
- 131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.